扫描二维码 分享好友和朋友圈
1.
These Regulations are the Regulation of Imports and Exports (Chewing Gum) (Amendment) Regulations 2016 and come into operation on 1 November 2016.
Amendment of regulation 2
2.
Regulation 2 of the Regulation of Imports and Exports (Chewing Gum) Regulations (Rg 4) (called in these Regulations the principal Regulations) is amended by deleting the definitions of “chewing gum with therapeutic value”, “medicinal product” and “oral dental gum” and substituting the following definitions:
“oral dental gum” means a health product categorised as an oral dental gum in the First Schedule to the Health Products Act;
“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Health Products Act.
”.
Deletion and substitution of regulation 3A
“
“health product” and “Register of Health Products” have the same meanings as in the Health Products Act (Cap. 122D);
Deletion and substitution of regulation 3A
3.
Regulation 3A of the principal Regulations is deleted and the following regulation substituted therefor:
Import of chewing gum for health-related purposes
3A.
Regulation 3 does not apply to any of the following:
(
a
)
any chewing gum that is registered or deemed to be registered as a therapeutic product under the Health Products Act (Cap. 122D) other than under the classification of a general sale list medicine in the Register of Health Products;
(
b
)
any chewing gum that is registered or deemed to be registered as an oral dental gum under the Health Products Act and —
(i)
contains calcium lactate at a concentration of between 2% and 5% weight in weight and xylitol at a concentration of between 12% and 36% weight in weight; or
(ii)
is sugarless and contains sodium hexametaphosphate at a concentration of between 1% and 2% weight in weight;
(
c
)
any other chewing gum that is registered as an oral dental gum under the Health Products Act and classified as a prescription‑only oral dental gum in the Register of Health Products.
”.Amendment of regulation 6
4.
Regulation 6 of the principal Regulations is amended by deleting the words “in respect of which a product licence has been granted under the Medicines Act (Cap. 176) that remains in force” and substituting the words “that is mentioned in regulation 3A(
a
), (
b
) or (
c
)”.
地区：
